Pages

Wednesday, April 20, 2016

FDA Law Blog: April 19, 2016 The FTC’s “Pay-for-Delay” Lawsuit Against Endo: Is There a Hole in the Commission’s Generic LIDODERM 180-Day Exclusivity Analysis? By Kurt R. Karst –

No comments:

Post a Comment